Financials

  • Market Capitalization 910.96 M
  • Employee 258
  • Founded 1990
  • CEO John A Scarlett
  • Website www.geron.com
  • Headquarter Delaware, United States
  • FIGI BBG000GX1891
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.15
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2525
ABUS
Arbutus Biopharma Corporation - Common Stock
4.67 USD-2.71%-6.22%+8.60%+44.58%922.50 M USD
2526
ANNX
Annexon, Inc. - common stock
5.63 USD-2.93%-6.01%+17.29%+114.07%922.43 M USD
2558
TBPH
Theravance Biopharma, Inc. - Ordinary Shares
16.90 USD-0.18%-0.59%+1.75%+17.77%871.25 M USD
2559
PHAT
Phathom Pharmaceuticals, Inc. - Common Stock
10.92 USD-13.40%-5.37%+5.81%+20.80%870.94 M USD

Frequently asked questions about Geron Corporation - Common Stock

What is the Geron Corporation - Common Stock stock price today?

The current price of Geron Corporation - Common Stock (GERN) is 1.42. Over the past 24 hours, the stock has changed by -5.33%. Follow the GERN chart for real-time price dynamics.

What is the stock ticker of Geron Corporation - Common Stock?

Geron Corporation - Common Stock trades under the ticker GERN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Geron Corporation - Common Stock stock going up?

GERN has changed by -1.39% over the last week, +22.41% over the last month, and +6.77% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Geron Corporation - Common Stock net income for the last quarter?

Geron Corporation - Common Stock reported net income of -3.64 M for the last quarter. The previous quarter showed -28.86 M, which means net income changed by +87.38%.

How many employees does Geron Corporation - Common Stock have?

As of the latest available data, Geron Corporation - Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.

What is Geron Corporation - Common Stock EBITDA?

Geron Corporation - Common Stock EBITDA is -625 K, and its EBITDA margin is -1.21%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Geron Corporation - Common Stock stock?

You can buy Geron Corporation - Common Stock (GERN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Geron Corporation - Common Stock stock?

Investing in Geron Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GERN chart and related analysis on metatrader.com as part of your research.

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

News